Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CleanSlate Centers is a leading national provider of outpatient addiction medicine, specializing in the treatment of opioid and alcohol use disorders. Founded in 2009, the company utilizes a physician-led, office-based model that focuses on Medication-Assisted Treatment (MAT) combined with behavioral health therapies. Their clinical approach primarily employs FDA-approved medications such as buprenorphine and naltrexone to help patients achieve long-term recovery. CleanSlate operates numerous centers across multiple states in the U.S., emphasizing a high-quality, evidence-based care delivery system that integrates with local healthcare ecosystems. The company is backed by Apple Tree Partners and has expanded significantly to address the national opioid crisis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CleanSlate Centers.